Erratum: Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with β-blockers (Science Translational Medicine DOI: 10.1126/scitranslmed.aao4307)

M. B. Nilsson, H. Sun, L. Diao, P. Tong, D. Liu, L. Li, Y. Fan, A. Poteete, Seung-Oe Lim, K. Howells, V. Haddad, D. Gomez, H. Tran, G. A. Pena, L. V. Sequist, J. C. Yang, J. Wang, E. S. Kim, R. Herbst, J. J. LeeW. K. Hong, I. Wistuba, M. C. Hung, A. K. Sood, J. V. Heymach

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the Research Article “Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with β-blockers,” the authors have provided additional competing interests, and the competing interests statements have been updated. In addition, one author's middle initial was added. The PDF and HTML (full text) have been corrected.

Original languageEnglish (US)
Article numbereaax9987
JournalScience translational medicine
Volume11
Issue number493
DOIs
StatePublished - May 22 2019

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Erratum: Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with β-blockers (Science Translational Medicine DOI: 10.1126/scitranslmed.aao4307)'. Together they form a unique fingerprint.

Cite this